Fenugreek, jamun and cinnamon are touted as miracle cures for diabetes. Aishwarya A Kumbhakoni shares if there's any scientific evidence to support this claim.

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Most people with type 2 diabetes should be offered SGLT-2 inhibitors much earlier in their treatment, final NICE guidance has ...

New dedicated spaces offer condition-specific education, peer support, and meaningful engagement opportunities for ...

Doctors should prescribe a sodium-glucose cotransporter-2 (SGLT-2) inhibitor alongside metformin to most patients with newly diagnosed type 2 diabetes, the National Institute for Health and Care ...

They found that 1.4 years after these medications were stopped, the cardiometabolic markers that they looked at, such as ...

Eli Lilly and Company LLY is one of the two clear leaders in the rapidly expanding diabetes and obesity treatment market, ...

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their ...

Taking magnesium and berberine together may lower blood sugar, but there is currently limited evidence supporting their ...

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors. Although rare, semaglutide initiation can lead to ...

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.